Ketojenik Diyet Tedavisinin Parenteral Kullanımı
Synopsis
Ketogenic diet therapy is a non-pharmacological enteral medical nutrition method used in drug-resistant epilepsy; however, when enteral intake becomes impossible due to conditions such as gastrointestinal infections, surgical interventions, status epilepticus, or febrile infection-related refractory status epilepticus (FIRES), parenteral ketogenic diet (PKD) therapy may be preferred. The main indications for PKD include patients currently receiving a ketogenic diet whose enteral feeding has been interrupted, as well as cases requiring the initiation of the diet due to refractory epilepsy who cannot be fed orally or enterally. Due to its high side-effect profile, it is recommended that the treatment be initiated strictly in an intensive care unit, metabolic contraindications be thoroughly evaluated, and it be administered in the absence of oral intake lasting longer than 48 hours. During treatment, all medications taken by the patient should be converted to carbohydrate-free formulations, ketosis should be supported by withholding glucose, protein intake should be maintained at a minimum of 1.5 g/kg/day, and lipid infusion should be initiated at 1-2 g/kg/day and gradually increased to a maximum of 4 g/kg/day. The dietary ratio should start at 1:1 and reach 2.0:1-2.9:1 within 3-4 days. Throughout the treatment, side effects such as hyperlipidemia, hypoglycemia, inadequate or excessive ketosis, and organ enzyme elevations—along with glucose, lipid, and β-hydroxybutyrate levels—must be closely monitored, and propofol use should be avoided. PKD therapy should ideally not exceed 7 days, and a transition to enteral feeding should be ensured as soon as the patient's medical condition permits.
References
Dressler A, Haiden N, Trimmel-Schwahofer P, et al. Ketogenic parenteral nutrition in 17 pediatric patients with epilepsy. Epilepsia Open 2017; 3: 30-39. doi: 10.1002/epi4.12084
Rosenthal E, Weissman B, Kyllonen K. Use of parenteral medium-chain triglyceride emulsion for maintaining seizure control in a 5-year-old girl with intractable diarrhea. JPEN J Parenter Enteral Nutr 1990; 14: 543-545. doi: 10.1177/0148607190014005543
Peng P, Peng J, Yin F, et al. Ketogenic Diet as a Treatment for Super-Refractory Status Epilepticus in Febrile Infection-Related Epilepsy Syndrome. Front Neurol. 2019 ; 10: 423. doi: 10.3389/fneur.2019.00423.
Lowe H, Segal S, Mouzaki M, Langos V, Dlamini N. Successful Management of Ketogenic Parenteral Nutrition: A Pediatric Case Study. JPEN J Parenter Enteral Nutr 2019; 43: 815-818. doi: 10.1002/jpen.1490
van der Louw E, Aldaz V, Harvey J, et al; Review Group. Optimal clinical management of children receiving ketogenic parenteral nutrition: a clinical practice guide. Dev Med Child Neurol 2020; 62: 48-56. doi: 10.1111/dmcn.14306
Corkins MR, Balint J. The A.S.P.E.N. Pediatric Nutrition Support Core Curriculum, 2nd ed. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition, 2015.
Joosten K, Embleton N, Yan W, Senterre T; ESPGHAN/ESPEN/ESPR/CSPEN working group on pediatric parenteral nutrition. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Energy. Clin Nutr. 2018; 37: 2309-2314. doi: 10.1016/j.clnu.2018.06.9
Mehta NM, Skillman HE, Irving SY, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Pediatric Critically Ill Patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition. JPEN J Parenter Enteral Nutr 2017; 41: 706-742. doi: 10.1177/0148607117711387
Lin JJ, Lin KL, Chan OW, Hsia SH, Wang HS; CHEESE Study Group. Intravenous ketogenic diet therapy for treatment of the acute stage of super-refractory status epilepticus in a pediatric patient. Pediatr Neurol 2015; 52: 442-445. doi: 10.1016/j.pediatrneurol.2014.12.008.
van Goudoever JB, Carnielli V, Darmaun D, Sainz de Pipaon M; ESPGHAN/ESPEN/ESPR/CSPEN working group on pediatric parenteral nutrition. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Amino acids. Clin Nutr 2018; 37: 2315-2323. doi: 10.1016/j.clnu.2018.06.945
Bronsky J, Campoy C, Braegger C, ESPGHAN/ESPEN/ESPR/CSPEN working group on pediatric parenteral nutrition. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Vitamins Clin Nutr. 2018; 37: 2366-2378. doi: 10.1016/j.clnu.2018.06.951
Soysal E, Gries H, Wray C. Pediatric patients on ketogenic diet undergoing general anesthesia-a medical record review. J Clin Anesth 2016; 35: 170-175. doi: 10.1016/j.jclinane.2016.04.010
Puntis J, Hojsak I, Ksiazyk J; ESPGHAN/ESPEN/ESPR/CSPEN working group on pediatric parenteral nutrition. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Organisational aspects. Clin Nutr 2018; 37: 2392-2400. doi:10.1016/j.clnu.2018.06.953